Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment
A phase 3 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 636 participants.
Also called NCT01620788
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 636 participants
- Sponsor
- EMS
- Registry
-
NCT01620788
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Suspended
Technical summary
Registry record NCT01620788. Randomized; no masking; primary purpose treatment. Start 2019-11-27 (actual); primary completion 2023-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment
- Condition
- Hypertension
- Intervention (Drug)
- Indapamide / Losartan
- Intervention (Drug)
- Indapamide / Losartan
- Intervention (Drug)
- Hyzaar®
- Intervention (Drug)
- Hyzaar®
- Lead sponsor
- EMS
Record details
- Record id
cardio:ct-nct01620788- Content hash
c8b148b6f8303272e25b9c806a8c9dd1c092217e9194a572a11741d0d1db73aa